Physician profile
Carter A King
NPI 1669579835
$60,911.76
in general payments reported to CMS, 2019-2025
46 companies · $8,938 in 2025
The $8,938 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,494 · 2020: $1,749 · 2021: $8,291 · 2022: $3,837 · 2023: $14K · 2024: $14K · 2025: $8,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Consulting Fee: $6,250 · Travel and Lodging: $6,016 · Grant: $5,500 · Education: $89.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,684.74 |
| Consulting Fee | $6,250.00 |
| Travel and Lodging | $6,016.26 |
| Grant | $5,500.00 |
| Education | $89.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,084.57 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Apollotm |
| Abbott Laboratories | $13,809.23 | 2019-2025 | Mitraclip, Triclip, Merlin@Home |
| Medtronic Vascular, INC. | $7,536.11 | 2019-2020 | |
| Edwards Lifesciences Corporation | $6,296.00 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $1,322.99 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,225.58 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $941.83 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $931.02 | 2019-2025 | |
| Boston Scientific Corporation | $927.81 | 2019-2025 | Watchman Access System, Watchman Flx, Eluvia |
| Shockwave Medical, INC | $777.67 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $569.13 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $412.97 | 2020-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $375.66 | 2019-2025 | Uptravi, Opsumit |
| Pfizer INC. | $373.87 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $302.89 | 2019-2023 | Farxiga, Brilinta |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $284.87 | 2019-2025 | IV Other, (5044) Mcot |
| Cardiovascular Systems INC. | $264.19 | 2019-2020 | |
| Amgen INC. | $252.94 | 2019-2025 | Repatha |
| Teleflex LLC | $225.35 | 2022-2025 | Guideliner, Manta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.67 | 2020-2025 | Jardiance |
| Amarin Pharma, INC. | $187.43 | 2019-2022 | |
| Intact Vascular, INC. | $175.00 | 2019 | |
| Heartflow, INC. | $168.07 | 2022-2023 | Ffrct |
| Biotronik INC. | $156.89 | 2022 | |
| Novo Nordisk INC | $137.67 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Itamar Medical INC | $111.52 | 2023-2025 | Watchpatone |
| Chiesi USA, INC. | $110.00 | 2020-2023 | Cleviprex, Kengreal |
| Scpharmaceuticals INC. | $105.34 | 2023-2024 | |
| Bard Peripheral Vascular, INC. | $69.98 | 2022 | |
| Alnylam Pharmaceuticals INC. | $61.68 | 2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $59.74 | 2023 | Optimizer |
| Angiodynamics, INC. | $59.18 | 2021-2025 | Alphavac |
| Daiichi Sankyo INC. | $55.42 | 2023 | Injectafer |
| Biosense Webster, INC. | $39.56 | 2019 | |
| Irhythm Technologies, INC. | $39.53 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $36.81 | 2025 | Assure Wcd |
| Cagent Vascular INC | $31.17 | 2023 | Serrantor |
| Sanofi-Aventis U.S. LLC | $30.55 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $24.94 | 2019 | |
| Innovation Technologies INC | $24.00 | 2024 | Irrisept |
| La Jolla Pharmaceutical Company | $21.25 | 2023 | Giapreza |
| Siemens Medical Solutions USA, INC. | $20.41 | 2019 | |
| Medicomp INC | $20.34 | 2023 | Telepatch Cardiac Monitor |
| Penumbra, INC. | $19.94 | 2022 | |
| Astellas Pharma US INC | $16.60 | 2020 | |
| Atricure, INC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.